We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...
The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...
Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis announced today that it received a second rejection from...
New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of Six Randomized Trials Published in JAMA...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite des marches financiers (AMF) -- the French stock market...
Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches financiers (AMF) -- the French stock market...
Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine for Clinical Trials SWIFTWATER, Pa., May 27...
Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that pending the...
Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients Findings Presented Suggest Minimal Potential for Adverse Effects Commonly Seen With Inhaled...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0005 | -16.6666666667 | 0.003 | 0.003 | 0.002 | 710257 | 0.00265807 | DE |
4 | 0.0005 | 25 | 0.002 | 0.003 | 0.001 | 1626446 | 0.00244949 | DE |
12 | -0.0005 | -16.6666666667 | 0.003 | 0.003 | 0.001 | 3500878 | 0.00211043 | DE |
26 | -0.0015 | -37.5 | 0.004 | 0.004 | 0.001 | 2198399 | 0.00228905 | DE |
52 | -0.0015 | -37.5 | 0.004 | 0.005 | 0.001 | 3160182 | 0.00334124 | DE |
156 | -0.0145 | -85.2941176471 | 0.017 | 0.023 | 0.001 | 2101081 | 0.0060778 | DE |
260 | -0.0015 | -37.5 | 0.004 | 0.045 | 0.001 | 2903114 | 0.0152004 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions